Pirkko Härkönen (Former)
41 – 50 of 60
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2005
-
Mark
Two-photon excitation in fluorescence polarization receptor-ligand binding assay
(
- Contribution to journal › Article
-
Mark
Sex specific expression of progesterone receptor in mouse lower urinary tract
(
- Contribution to journal › Article
-
Mark
Estrogen responsiveness of bone formation in vitro and altered bone phenotype in aged estrogen receptor-alpha-deficient male and female mice
(
- Contribution to journal › Article
-
Mark
Cleavable ErbB4 isoform in estrogen receptor-regulated growth of breast cancer cells
(
- Contribution to journal › Article
-
Mark
Estrogen protects primary osteocytes against glucocorticoid-induced apoptosis
(
- Contribution to journal › Article
-
Mark
Estrogen and testosterone use different cellular pathways to inhibit osteoclastogenesis and bone resorption
(
- Contribution to journal › Article
-
Mark
Role of mitochondria in tamoxifen-induced rapid death of MCF-7 breast cancer cells
(
- Contribution to journal › Article
- 2004
-
Mark
Role of estrogens in development of prostate cancer.
(
- Contribution to journal › Scientific review
-
Mark
Osteoblast-like cells complete osteoclastic bone resorption and form new mineralized bone matrix in vitro
(
- Contribution to journal › Article
-
Mark
Re S. S. Virtanen et al., Alendronate inhibits invasion of PC-3 prostate cancer cells by affecting the mevalonate pathway. Cancer Res 2002;62 : 2708-14 - Re K. Sawada et al., Alendronate inhabits lysophosphatidic acid-induced migration of human ovarian cancer cells by attenuating the activation of Rho. Cancer Res 2002;62 : 6015-20 - Reply
(
- Contribution to journal › Letter